Candesartan PCD Pharma Franchise Company
Cafoli Lifecare is a trusted Candesartan PCD pharma franchise company in India, offering a focused range of 4 Candesartan formulations manufactured at WHO-GMP certified facilities. We supply consistent, DCGI-approved antihypertensive products to franchise partners and distributors who need dependable stock and district-wise monopoly support.
What is Candesartan?
Candesartan is an angiotensin II receptor blocker that relaxes blood vessels by blocking the AT1 receptor. It is used to treat high blood pressure and heart failure. Learn more from the PubChem compound record.
Available Candesartan Formulations
Our current Candesartan portfolio spans 4 Candesartan formulations available in the following forms: Tablets. Every batch is quality tested and released under WHO-GMP controls to ensure uniform quality across supply cycles.
Therapeutic Applications
Candesartan is indicated for hypertension and chronic heart failure. It is prescribed by cardiologists, nephrologists and general physicians and is dispensed strictly on prescription under qualified medical supervision.
Why Candesartan is a High-Potential Molecule for Distributors
Hypertension is one of the largest chronic-disease markets in India, and ARBs like candesartan deliver long-term, refill-driven demand that anchors a cardio-diabetic range.
Why Choose Cafoli Lifecare
Partners receive district-wise monopoly rights, WHO-GMP certified manufacturing, DCGI-approved formulations, complete promotional inputs, and the backing of a network of 1000+ franchise partners across India. Our supply reliability and compliance-first approach help you build a durable Candesartan franchise business.
References
- PubChem: Candesartan
- MedlinePlus: Candesartan
- PubMed: Candesartan research
Our formulations of Candesartan find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to: